+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Infertility Treatment Market Research Report by Product (Accessories, Equipment, and Media & Consumables), Procedure, Patient type, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 121 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5533336
UP TO OFF until Dec 31st 2022
The United States Infertility Treatment Market size was estimated at USD 727.44 million in 2021, USD 806.73 million in 2022, and is projected to grow at a CAGR 10.96% to reach USD 1,358.09 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Infertility Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices.
  • Based on Procedure, the market was studied across Artificial Insemination, Assisted Reproductive Technology, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology is further studied across In Vitro Fertilization, Intracytoplasmic Sperm Injection, and Surrogacy. The In Vitro Fertilization is further studied across Gamete Donation and Intracytoplasmic Morphologically Selected Sperm Injection. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Laparotomy, Microsurgical Reconstruction, Myomectomy, Tubal Ligation Reversal, and Varicocelectomy. The Microsurgical Reconstruction is further studied across Vasoepididymostomy and Vasovasostomy.
  • Based on Patient type, the market was studied across Female Infertility Treatment and Male Infertility Treatment.
  • Based on End User, the market was studied across Cryobanks, Fertility Centers, Hospitals & Surgical Clinics, and Research Institutes.
  • Based on State, the market was studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Infertility Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Infertility Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Infertility Treatment Market, including Abbott Laboratories, Carl Zeiss AG, Cook Medical Incorporated, Esco Micro Pte. Ltd., Ferring Pharmaceuticals, Inc., FUJIFILM Irvine Scientific, Genea Biomedx, Hamilton Thorne Ltd., IHMedical A/S, IVFtech ApS, Kitazato Corporation, Livzon Pharmaceutical Group Inc., MedGyn Products, Inc., Merck KGaA, Par Pharmaceutical, Inc., Rocket Medical PLC, The Cooper Companies Inc., Thermo Fisher Scientific Inc., and Vitrolife.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Infertility Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Infertility Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Infertility Treatment Market?
4. What is the competitive strategic window for opportunities in the United States Infertility Treatment Market?
5. What are the technology trends and regulatory frameworks in the United States Infertility Treatment Market?
6. What is the market share of the leading vendors in the United States Infertility Treatment Market?
7. What modes and strategic moves are considered suitable for entering the United States Infertility Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Infertility Rate and Delayed Pregnancy in Women in the U.S.
5.1.1.2. Increasing Popularity of IVF in the U.S and the Growing Number of Fertility Clinics
5.1.2. Restraints
5.1.2.1. High Costs and Lack of Insurance Coverage Associated with Infertility Treatments
5.1.3. Opportunities
5.1.3.1. Technological Advancements of IVF Procedures
5.1.3.2. Increasing Utilization of Fertility Treatment from Single Parents
5.1.4. Challenges
5.1.4.1. High Treatment Failure Rates and Social Stigma Surrounding Infertility Treatments
5.2. Cumulative Impact of COVID-19
6. Infertility Treatment Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Equipment
6.3.1. Cryosystems
6.3.2. Gas Analyzers
6.3.3. Imaging Systems
6.3.4. Incubators
6.3.5. Laser Systems
6.3.6. Micromanipulator Systems
6.3.7. Microscopes
6.3.8. Ovum Aspiration Pumps
6.3.9. Sperm Analyzer Systems
6.3.10. Sperm Separation Devices
6.4. Media & Consumables
7. Infertility Treatment Market, by Procedure
7.1. Introduction
7.2. Artificial Insemination
7.2.1. Intracervical Insemination
7.2.2. Intratubal Insemination
7.2.3. Intrauterine Insemination
7.3. Assisted Reproductive Technology
7.3.1. In Vitro Fertilization
7.3.1.1. Gamete Donation
7.3.1.2. Intracytoplasmic Morphologically Selected Sperm Injection
7.3.2. Intracytoplasmic Sperm Injection
7.3.3. Surrogacy
7.4. Fertility Surgeries
7.4.1. Hysteroscopy
7.4.2. Laparoscopy
7.4.3. Laparotomy
7.4.4. Microsurgical Reconstruction
7.4.4.1. Vasoepididymostomy
7.4.4.2. Vasovasostomy
7.4.5. Myomectomy
7.4.6. Tubal Ligation Reversal
7.4.7. Varicocelectomy
8. Infertility Treatment Market, by Patient type
8.1. Introduction
8.2. Female Infertility Treatment
8.3. Male Infertility Treatment
9. Infertility Treatment Market, by End User
9.1. Introduction
9.2. Cryobanks
9.3. Fertility Centers
9.4. Hospitals & Surgical Clinics
9.5. Research Institutes
10. California Infertility Treatment Market11. Connecticut Infertility Treatment Market12. Florida Infertility Treatment Market13. Illinois Infertility Treatment Market14. Maryland Infertility Treatment Market15. Minnesota Infertility Treatment Market16. New Jersey Infertility Treatment Market17. New York Infertility Treatment Market18. Ohio Infertility Treatment Market19. Pennsylvania Infertility Treatment Market20. Texas Infertility Treatment Market21. Washington Infertility Treatment Market
22. Competitive Landscape
22.1. FPNV Positioning Matrix
22.1.1. Quadrants
22.1.2. Business Strategy
22.1.3. Product Satisfaction
22.2. Market Ranking Analysis
22.3. Market Share Analysis, By Key Player
22.4. Competitive Scenario
22.4.1. Merger & Acquisition
22.4.2. Agreement, Collaboration, & Partnership
22.4.3. New Product Launch & Enhancement
22.4.4. Investment & Funding
22.4.5. Award, Recognition, & Expansion
23. Company Usability Profiles
23.1. Abbott Laboratories
23.2. Carl Zeiss AG
23.3. Cook Medical Incorporated
23.4. Esco Micro Pte. Ltd.
23.5. Ferring Pharmaceuticals, Inc.
23.6. FUJIFILM Irvine Scientific
23.7. Genea Biomedx
23.8. Hamilton Thorne Ltd.
23.9. IHMedical A/S
23.10. IVFtech ApS
23.11. Kitazato Corporation
23.12. Livzon Pharmaceutical Group Inc.
23.13. MedGyn Products, Inc.
23.14. Merck KGaA
23.15. Par Pharmaceutical, Inc.
23.16. Rocket Medical PLC
23.17. The Cooper Companies Inc.
23.18. Thermo Fisher Scientific Inc.
23.19. Vitrolife
24. Appendix
24.1. Discussion Guide
24.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES INFERTILITY TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES INFERTILITY TREATMENT MARKET DYNAMICS
FIGURE 8. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, 2019-2027 (USD MILLION)
FIGURE 34. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2019-2027 (USD MILLION)
FIGURE 36. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2021 VS 2027 (%)
FIGURE 38. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2021 VS 2027 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2027
FIGURE 40. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 46. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, 2019-2027 (USD MILLION)
FIGURE 47. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 48. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2019-2027 (USD MILLION)
FIGURE 49. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 50. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2019-2027 (USD MILLION)
FIGURE 51. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 52. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY GAMETE DONATION, 2019-2027 (USD MILLION)
FIGURE 53. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY GAMETE DONATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 54. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION, 2019-2027 (USD MILLION)
FIGURE 55. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 56. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, 2019-2027 (USD MILLION)
FIGURE 57. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 58. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SURROGACY, 2019-2027 (USD MILLION)
FIGURE 59. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SURROGACY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 60. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2019-2027 (USD MILLION)
FIGURE 61. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 62. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, 2019-2027 (USD MILLION)
FIGURE 63. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 64. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, 2019-2027 (USD MILLION)
FIGURE 65. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 66. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LAPAROTOMY, 2019-2027 (USD MILLION)
FIGURE 67. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LAPAROTOMY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 68. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2019-2027 (USD MILLION)
FIGURE 69. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 70. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VASOEPIDIDYMOSTOMY, 2019-2027 (USD MILLION)
FIGURE 71. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VASOEPIDIDYMOSTOMY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 72. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VASOVASOSTOMY, 2019-2027 (USD MILLION)
FIGURE 73. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VASOVASOSTOMY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 74. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, 2019-2027 (USD MILLION)
FIGURE 75. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 76. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY TUBAL LIGATION REVERSAL, 2019-2027 (USD MILLION)
FIGURE 77. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY TUBAL LIGATION REVERSAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 78. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, 2019-2027 (USD MILLION)
FIGURE 79. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 80. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2021 VS 2027 (%)
FIGURE 81. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 82. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2027
FIGURE 83. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY TREATMENT, 2019-2027 (USD MILLION)
FIGURE 84. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY TREATMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 85. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY TREATMENT, 2019-2027 (USD MILLION)
FIGURE 86. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY TREATMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 87. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 88. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 89. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2027
FIGURE 90. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, 2019-2027 (USD MILLION)
FIGURE 91. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 92. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CENTERS, 2019-2027 (USD MILLION)
FIGURE 93. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CENTERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 94. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS & SURGICAL CLINICS, 2019-2027 (USD MILLION)
FIGURE 95. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS & SURGICAL CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 96. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 97. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 98. CALIFORNIA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. CONNECTICUT INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. FLORIDA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. ILLINOIS INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. MARYLAND INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. MINNESOTA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. NEW JERSEY INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. NEW YORK INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. OHIO INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 107. PENNSYLVANIA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 108. TEXAS INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 109. WASHINGTON INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 110. UNITED STATES INFERTILITY TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 111. UNITED STATES INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 112. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES INFERTILITY TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY GAMETE DONATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY SURROGACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY LAPAROTOMY, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VASOEPIDIDYMOSTOMY, BY STATE, 2019-2027 (USD MILLION)
TABLE 36. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VASOVASOSTOMY, BY STATE, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY TUBAL LIGATION REVERSAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 41. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS & SURGICAL CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. CALIFORNIA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. CALIFORNIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 50. CALIFORNIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 51. CALIFORNIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 52. CALIFORNIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 53. CONNECTICUT INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. CONNECTICUT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 55. CONNECTICUT INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 56. CONNECTICUT INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 57. CONNECTICUT INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 58. FLORIDA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. FLORIDA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 60. FLORIDA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 61. FLORIDA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 62. FLORIDA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 63. ILLINOIS INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. ILLINOIS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 65. ILLINOIS INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 66. ILLINOIS INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 67. ILLINOIS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 68. MARYLAND INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. MARYLAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 70. MARYLAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 71. MARYLAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 72. MARYLAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 73. MINNESOTA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. MINNESOTA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 75. MINNESOTA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 76. MINNESOTA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 77. MINNESOTA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 78. NEW JERSEY INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. NEW JERSEY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 80. NEW JERSEY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 81. NEW JERSEY INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 82. NEW JERSEY INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 83. NEW YORK INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. NEW YORK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 85. NEW YORK INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 86. NEW YORK INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 87. NEW YORK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 88. OHIO INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. OHIO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 90. OHIO INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 91. OHIO INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 92. OHIO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 93. PENNSYLVANIA INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. PENNSYLVANIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 95. PENNSYLVANIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 96. PENNSYLVANIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 97. PENNSYLVANIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 98. TEXAS INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. TEXAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 100. TEXAS INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 101. TEXAS INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 102. TEXAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 103. WASHINGTON INFERTILITY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. WASHINGTON INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 105. WASHINGTON INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2019-2027 (USD MILLION)
TABLE 106. WASHINGTON INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2019-2027 (USD MILLION)
TABLE 107. WASHINGTON INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 108. UNITED STATES INFERTILITY TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 109. UNITED STATES INFERTILITY TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 110. UNITED STATES INFERTILITY TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 111. UNITED STATES INFERTILITY TREATMENT MARKET RANKING
TABLE 112. UNITED STATES INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 113. UNITED STATES INFERTILITY TREATMENT MARKET MERGER & ACQUISITION
TABLE 114. UNITED STATES INFERTILITY TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 115. UNITED STATES INFERTILITY TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 116. UNITED STATES INFERTILITY TREATMENT MARKET INVESTMENT & FUNDING
TABLE 117. UNITED STATES INFERTILITY TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 118. UNITED STATES INFERTILITY TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Carl Zeiss AG
  • Cook Medical Incorporated
  • Esco Micro Pte. Ltd.
  • Ferring Pharmaceuticals, Inc.
  • FUJIFILM Irvine Scientific
  • Genea Biomedx
  • Hamilton Thorne Ltd.
  • IHMedical A/S
  • IVFtech ApS
  • Kitazato Corporation
  • Livzon Pharmaceutical Group Inc.
  • MedGyn Products, Inc.
  • Merck KGaA
  • Par Pharmaceutical, Inc.
  • Rocket Medical PLC
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife

Methodology

Loading
LOADING...